Proteolytic patterns of head and neck squamous cell carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 256, Issue 7, 1999, Pages 346-350

  Schmidt, M ^a   Polednik, C ^a   Hoppe, F ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Densitometry; Head and neck neoplasms; Plasminogen activators; Squamous cell carcinoma; Tumor gelatinases

Indexed keywords

GELATINASE A; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; HEAD CANCER; HUMAN; HUMAN TISSUE; MUCOSA; NECK CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; SQUAMOUS CELL CARCINOMA; ZYMOGRAPHY;

CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; HUMANS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOUTH MUCOSA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032886362     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004050050161     Document Type: Article

References (19)

1. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22
2. Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735
3. Charous SJ, Stricklin GP, Netterville JL, Nanney LB, Burke BB (1997) Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 106:271-278
4. Clayman G, Wang SW, Nicolson GL, El-Naggar A, Mazar A, Henkin J, Blasi F, Goepfert H, Boyd D (1993) Regulation of urokinase-type plasminogen activator expression in squamous cell carcinoma of the oral cavity. Int J Cancer 54:73-80
5. Danglot G, Vinson D, Chapeville F (1986) Qualitative and quantitative distribution of plasminogen activators in organs from healthy adult mice. FEBS Lett 194:96-100
6. Duffy MJ, O'Grady P, Devaney D, O'Siorain E, Fennelly JJ, Lijnen HJ (1988) Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report. Cancer 62:531-533
7. Heussen D, Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196-202
8. Itaya T, Motai H, Suzuki K, Baba S (1995) Immunohistological study of fibrinolytic factors of head and neck squamous carcinomas. Nippon Jibiinkoka Gakkai Kaiho 98:197-202
9. Juarez J, Clayman G, Nakajima M, Tanabe KK, Saya H, Nicolson GL, Boyd D (1993) Role and regulation of expression of 92 kDa type-IV collagenase in 2 invasive squamous cell carcinoma cell lines of the oral cavity. Int J Cancer 55:10-18
10. Kawata R, Shinomiya T, Yasuda N, Takenaka H, Murakami Y (1996) Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance. Nippon Jibiinkoka Gakkai Kaiho 99:299-305
11. Koshiba T, Hosotani R, Wada M, Miyamoto Y, Fujimoto K, Lee JU, Doi R, Arii S, Imamura M (1998) Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 82:642-650
12. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M (1993) Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathological study. Am J Clin Pathol 99:18-23
13. Lowry OH, Rosebrough NNJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
14. Miyajima Y, Nakano R, Morimatsu M (1995) Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 104:678-684
15. Sawaya R, Highsmith R (1988) Plasminogen activator activity and molecular weight patterns in human brain tumors. J Neurosurg 68:73-79
16. Sier CF, Kubben FJ, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, van Krieken JH, Lamer CB, Verspaget HW (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the oberall survival of patients with gastric carcinoma. Br J Cancer 74:413-417
17. Simon C, Juarez J, Nicolson GL, Boyd D (1996) Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. Cancer Res 56:5369-5374
18. Wysocki AB, Staiano-Coico L, Grinnell F (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-68
19. Yasuda T, Sakata Y, Kitamura K, Morita M, Ishida T (1997) Localization of plasminogen activators and their inhibitor in squamous cell carcinoma of the head and neck. Head Neck 19: 611-616